Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Change in Receivables (2024 - 2025)

Onconetix (ONCO) has disclosed Change in Receivables for 1 consecutive years, with -$67597.0 as the latest value for Q4 2024.

  • On a quarterly basis, Change in Receivables changed N/A to -$67597.0 in Q4 2024 year-over-year; TTM through Dec 2024 was -$116676.0, a N/A change, with the full-year FY2024 number at -$116676.0, down 287.32% from a year prior.
  • Change in Receivables was -$67597.0 for Q4 2024 at Onconetix, up from -$80580.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $116763.0 in Q1 2024 to a low of -$85262.0 in Q2 2024.